BioSpace News Archive

Genetown

Regenacy Pharma Earns $30 Million Series A to Advance Diabetic Neuropathy Drug

“We are fortunate to have the strong support of investors aligned with our mission to provide lasting relief of all symptoms of diabetic peripheral neuropathy,” said Simon Jones, Regenacy’s president and chief executive officer.

March 26, 2020
·
2 min read
·
Mark Terry
FDA

BMS’ Ozanimod Wins FDA Approval for Relapsing Multiple Sclerosis

Although Zeposia has now been approved in the United States, BMS said it was delaying commercialization due to the “unprecedented COVID-19 pandemic.”

March 26, 2020
·
2 min read
·
Alex Keown
GlobalData Report Expresses Concern Over Global Drug Supply Chain

GlobalData issued a statement that the COVID-19 pandemic threatens biopharma in-house manufacturing.

March 26, 2020
·
4 min read
·
Mark Terry
Ipsen Pushes Forward in FOP Program Despite Ongoing Hold

A partial clinical hold placed at the end of last year remains in effect and the company has opted to terminate a trial in patients with multiple osteochondromas.

March 26, 2020
·
3 min read
·
Alex Keown
Making the Most of Your Career Event Experience

A career event provides an excellent opportunity to get your face in front of multiple employers all on the same day. But to best leverage that opportunity takes careful preparation.

March 26, 2020
·
4 min read
·
Katharine Hansen, PhD
Bio NC

Research Roundup: Social Distancing Works and More

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

March 26, 2020
·
5 min read
·
Mark Terry
Some Drugs Being Rationed as Suppliers Continue to See Increased Orders

Lab suppliers report sales and backorders are up, and some distributors are allocating medications. For most biotech companies, supplies are available, although they are monitoring the situation closely.

March 26, 2020
·
4 min read
·
Gail Dutton
Deals

Mylan and Upjohn Delay Close of Merger Due to COVID-19 Pandemic

The delays, particularly in the regulatory review process, have caused the merger completion to be pushed back to the second half of this year.

March 26, 2020
·
2 min read
·
Alex Keown
BioCapital

BioSpace Movers & Shakers, March 27

Pharma and life sciences companies from across the globe provide updates on their pipelines and business.

March 26, 2020
·
4 min read
·
Alex Keown
Drug Development

Biopharma Industry News for March 26: Update on the Novel Coronavirus

A summary of daily biopharma industry news. Please check out stories that are trending on March 26, 2020.

March 26, 2020
·
5 min read
·
BioSpace Editorial Staff